DIABETES MELLITUS Y COVID-19

Practical recommendations for the management of diabetes in patients with COVID-19.

Lancet Diabetes Endocrinol. 2020 Apr 23. pii: S2213-8587(20)30152-2.

https://doi-org.pbidi.unam.mx:2443/10.1016/S2213-8587(20)30152-2

https://www-sciencedirect-com.pbidi.unam.mx:2443/science/article/pii/S2213858720301522?via%3Dihub

Endocrinology in the time of COVID-19: Management of Diabetes insipidus and Hyponatraemia.

Eur J Endocrinol. 2020 Apr 1.

https://doi.org/10.1530/EJE-20-0338

https://eje-bioscientifica-com.pbidi.unam.mx:2443/view/journals/eje/aop/eje-20-0338/eje-20-0338.xml

COVID-19 and diabetes mellitus: what we know, how our patients should be treated now, and what should happen next.

Metabolism. 2020 Apr 19:154245.

https://doi.org/10.1016/j.metabol.2020.154245

https://www-sciencedirect-com.pbidi.unam.mx:2443/science/article/pii/S0026049520301098?via%3Dihub

Endocrine and metabolic link to coronavirus infection.

Nat Rev Endocrinol. 2020 Apr 2.

https://doi.org/10.1038/s41574-020-0353-9

https://www-ncbi-nlm-nih-gov.pbidi.unam.mx:2443/pubmed/?term=Endocrine+and+metabolic+link+to+coronavirus+infection

Diabetes self-management amid COVID-19 pandemic.

Diabetes Metab Syndr. 2020 Apr 13;14(4):351-354.

https://doi.org/10.1016/j.dsx.2020.04.013

https://www-sciencedirect-com.pbidi.unam.mx:2443/science/article/pii/S1871402120300783?via%3Dihub

Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infection with reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc).

Diabetes Metab Syndr. 2020 May – Jun;14(3):251-254.

https://doi.org/10.1016/j.dsx.2020.03.012

https://www-sciencedirect-com.pbidi.unam.mx:2443/science/article/pii/S1871402120300527?via%3Dihub

Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries. Diabetes Metab Syndr. 2020 May – Jun;14(3):241-246.

https://doi.org/10.1016/j.dsx.2020.03.011

https://www-sciencedirect-com.pbidi.unam.mx:2443/science/article/pii/S1871402120300515?via%3Dihub

COVID‐19 and diabetes. Diabet Med. 2020 May;37(5):723-725.

https://doi-org.pbidi.unam.mx:2443/10.1111/dme.14300

https://onlinelibrary-wiley-com.pbidi.unam.mx:2443/doi/full/10.1111/dme.14300

COVID-19, diabetes mellitus and ACE2: The conundrum. Diabetes Res Clin Pract. 2020 Mar 29;162:108132.

https://doi.org/10.1016/j.diabres.2020.108132

https://www-sciencedirect-com.pbidi.unam.mx:2443/science/article/pii/S016882272030382X?via%3Dihub

Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics. Diabetes Metab Res Rev. 2020 Mar 31:e33213321.

https://doi-org.pbidi.unam.mx:2443/10.1002/dmrr.3321

https://onlinelibrary-wiley-com.pbidi.unam.mx:2443/doi/full/10.1002/dmrr.3321

Our Response to COVID-19 as Endocrinologists and Diabetologists. J Clin Endocrinol Metab. 2020 May 1;105(5). pii: dgaa148

https://doi-org.pbidi.unam.mx:2443/10.1210/clinem/dgaa148

https://academic-oup-com.pbidi.unam.mx:2443/jcem/article/105/5/dgaa148/5814115

Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis. Arch Acad Emerg Med. 2020 Mar 24;8(1):e35. eCollection 2020.

https://www-ncbi-nlm-nih-gov.pbidi.unam.mx:2443/pmc/articles/PMC7096724/

Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabetes Metab Syndr. 2020 May-Jun;14(3):211-212.

https://doi.org/10.1016/j.dsx.2020.03.002

https://www-sciencedirect-com.pbidi.unam.mx:2443/science/article/pii/S1871402120300424?via%3Dihub

COVID-19 and diabetes: Can DPP4 inhibition play a role?. Diabetes Res Clin Pract. 2020 Mar 26;162:108125.

https://doi.org/10.1016/j.diabres.2020.108125

https://www-sciencedirect-com.pbidi.unam.mx:2443/science/article/pii/S0168822720303752?via%3Dihub

COVID-19 and diabetes: Knowledge in progress. Diabetes Res Clin Pract. 2020 Apr 9;162:108142.

https://doi.org/10.1016/j.diabres.2020.108142

https://www-sciencedirect-com.pbidi.unam.mx:2443/science/article/pii/S0168822720303922?via%3Dihub

Diabetes is a risk factor for the progression and prognosis of COVID-19.

Diabetes Metab Res Rev. 2020 Mar 31:e3319.

https://doi-org.pbidi.unam.mx:2443/10.1002/dmrr.3319

https://onlinelibrary-wiley-com.pbidi.unam.mx:2443/doi/full/10.1002/dmrr.3319

Comentarios desactivados en DIABETES MELLITUS Y COVID-19